Literature DB >> 16172490

Status of Plasmodium vivax malaria in the Republic of Korea during 2001-2003.

Joon-Sup Yeom1, Seung-Ho Ryu, Sejoong Oh, Won-Ja Lee, Tae-Seon Kim, Ki-Hwan Kim, Young-A Kim, Sun-Young Ahn, Je-Eun Cha, Jae-Won Park.   

Abstract

The Republic of Korea experienced a re-emergence of Plasmodium vivax malaria in 1993. The incidence of this disease increased rapidly through 2000 with its geographic distribution expanding from the vicinity near the Demilitarized Zone to the adjacent outlying areas. However, the number of cases of P. vivax malaria since that time period has decreased. A total of 2,538 cases occurred in 2001, and this decreased to 1,761 cases and 1,164 cases in the two subsequent years. A total of 5,463 cases of P. vivax malaria were reported from 2001 through 2003; 25.26% (1,380) were reported among Republic of Korea military personnel, 27.48% (1,501) were among veterans who had been discharged from the military within two years, and 47.26% (2,582) were among the civilian population. Mosquito control activities by the North Korean and South Korean governments, chemoprophylaxis of Republic of Korea Army personnel, and the low level of Anopheles mosquitoes in 2001 may have been factors responsible for the decreasing number of malaria cases. However, local transmission might have taken place in urban regions of the malaria-risk areas that are within 30 km south of the Demilitarized Zone. Extensive intervention and continued surveillance are warranted to prevent the epidemic from re-expanding and to eliminate this disease in the Republic of Korea.

Entities:  

Mesh:

Year:  2005        PMID: 16172490

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  16 in total

1.  Reemerging vivax malaria: changing patterns of annual incidence and control programs in the Republic of Korea.

Authors:  Eun-Taek Han; Duk-Hyoung Lee; Ki-Dong Park; Won-Seok Seok; Young-Soo Kim; Takafumi Tsuboi; Eun-Hee Shin; Jong-Yil Chai
Journal:  Korean J Parasitol       Date:  2006-12       Impact factor: 1.341

2.  Usefulness of the recombinant liver stage antigen-3 for an early serodiagnosis of Plasmodium falciparum infection.

Authors:  Hyeong-Woo Lee; Sung-Ung Moon; Hye-Sun Ryu; Yeon-Joo Kim; Shin-Hyeong Cho; Gyung-Tae Chung; Khin Lin; Byoung-Kuk Na; Yoon Kong; Kyung-Suk Chung; Tong-Soo Kim
Journal:  Korean J Parasitol       Date:  2006-03       Impact factor: 1.341

3.  Sequence polymorphisms in Pvs48/45 and Pvs47 gametocyte and gamete surface proteins in Plasmodium vivax isolated in Korea.

Authors:  Mi Kyung Woo; Kyeong Ah Kim; JuYeon Kim; Jun Seo Oh; Eun Taek Han; Seong Soo A An; Chae Seung Lim
Journal:  Mem Inst Oswaldo Cruz       Date:  2013-05       Impact factor: 2.743

Review 4.  Plasmodium vivax malaria: status in the Republic of Korea following reemergence.

Authors:  Jae-Won Park; Gyo Jun; Joon-Sup Yeom
Journal:  Korean J Parasitol       Date:  2009-10       Impact factor: 1.341

5.  Parasitemia characteristics of Plasmodium vivax malaria patients in the Republic of Korea.

Authors:  Ae-Jung Huh; Yee Gyung Kwak; Eu Suk Kim; Kkot Sil Lee; Joon-Sup Yeom; Yong-Kyun Cho; Chang-Seok Kim; Jae-Won Park
Journal:  J Korean Med Sci       Date:  2010-12-22       Impact factor: 2.153

6.  Therapeutic efficacy of chloroquine in Plasmodium vivax and the pvmdr1 polymorphisms in the Republic of Korea under mass chemoprophylaxis.

Authors:  Young Keun Kim; Changsoo Kim; Inho Park; Hyo Youl Kim; Jun Yong Choi; June Myung Kim
Journal:  Am J Trop Med Hyg       Date:  2011-04       Impact factor: 2.345

7.  Risk analysis of the re-emergence of Plasmodium vivax malaria in Japan using a stochastic transmission model.

Authors:  Tomoyuki Bitoh; Kaoru Fueda; Hiroshi Ohmae; Mamoru Watanabe; Hirofumi Ishikawa
Journal:  Environ Health Prev Med       Date:  2010-10-26       Impact factor: 3.674

8.  Pharmacokinetics of hydroxychloroquine and its clinical implications in chemoprophylaxis against malaria caused by Plasmodium vivax.

Authors:  Hyeong-Seok Lim; Jeong-Soo Im; Joo-Youn Cho; Kyun-Seop Bae; Terry A Klein; Joon-Sup Yeom; Tae-Seon Kim; Jae-Seon Choi; In-Jin Jang; Jae-Won Park
Journal:  Antimicrob Agents Chemother       Date:  2009-02-02       Impact factor: 5.191

9.  Antimalarial drug susceptibility of Plasmodium vivax in the Republic of Korea.

Authors:  Kesinee Chotivanich; Jetsumon Sattabongkot; Yien Kyong Choi; Jae Sun Park; Juntima Sritabal; Chae Seung Lim; Rachanee Udomsangpetch; Nicholas J White; Won Ja Lee
Journal:  Am J Trop Med Hyg       Date:  2009-06       Impact factor: 2.345

10.  Determination of the Plasmodium vivax relapse pattern in Camopi, French Guiana.

Authors:  Matthieu Hanf; Aurélia Stéphani; Célia Basurko; Mathieu Nacher; Bernard Carme
Journal:  Malar J       Date:  2009-12-04       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.